You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. QuickVentric External Ventricular Monitor and Drain System for Rapid, Far-Forward TBI Stabilization

    SBC: CRITICAL INNOVATIONS LLC            Topic: DHA17010

    Defense Health Program (DHP) seeks to develop a new and innovative point of injury device to manage patients with moderate-to-severe Traumatic Brain Injury (TBI). Critical Innovations, NeoMatRx, and KARA & Associates, with consultants Captain David Plurad, MD, FACS (USN, Ret.) and neurosurgeon Michael Levy, MD, PhD., have formed a team of medical device, trauma, and neurosurgical experts to addres ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  2. Cerebral Trauma Recovery (CereTRec) drug delivery system

    SBC: CHROMOLOGIC LLC            Topic: DHA17011

    In order to meet the Defense Health Agencys need for addressing the prevention of secondary brain injury from moderate, severe and penetrating traumatic brain injury (TBI), ChromoLogic proposes to develop a cerebral trauma recovery (CereTRec) drug delivery system. In particular, CereTRec aims to treat TBI during prolonged field care (PFC) to stabilize casualties who sustain a moderate-severe TBI. ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  3. Diagnostic device for detecting biomarkers of early multiorgan injury in saliva

    SBC: NANOCOMPOSIX, INC.            Topic: DHP16006

    Combat soldiers are exposed to vast numbers of dangerous chemicals with potentially adverse health outcomes. This SBIR proposal aims to develop a new class of saliva based diagnostic assays that will measure the bodys response to toxic chemical exposure with a panel of clinically validated biomarkers that are indicative of organ injury. The tests will leverage the proven functionality of lateral ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  4. Personalized Warrior Health Avatar

    SBC: CFD RESEARCH CORPORATION            Topic: DHP16001

    The confluence of genetics, mobile computing, wearable sensors and computational physiology has started the revolution in personalized medicine with huge civilian and military prospects to promote health and reduce costs. The goal of this project is to develop and demonstrate a Warfighter Health Avatar (WHA): a framework and physiology based modeling tools of a warfighter body to enable assessment ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  5. 3D Printing of Low-Cost Synthetic Tissues

    SBC: Advanced Life Technologies, LLC            Topic: DHP12003

    Surgical trainingrequires an understanding of the human body’scomplex3-dimensional anatomical structures and thespatial relationships of nerves, blood vessels and othervital structures.Learningthesespatial skills requires a lengthy training period and much practicethat usually takes placein the operatingroom while under thesupervision of a senior surgeon atgreat financial cost and potential risk ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  6. A New Class of Non-Opioid Analgesics for Use in Chronic Pain Management

    SBC: Kalyra Pharmaceuticals, Inc.            Topic: NonDOD

    There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAP

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  7. Cell Phone-based Early Detection of Multi-Organ Injury Biomarkers in Saliva

    SBC: INTELLIGENT OPTICAL SYSTEMS, INC.            Topic: DHP16006

    Rapid diagnosis in conflict areas is a growingmilitary need, as troops areexposed to chemical threats (http://www.army.mil/e2/c/downloads/351235.pdf). Testingfor biomarkers in saliva has recently shown great promisein diagnostics, prognostics, and treatmentefficacy follow-up. In addition to itsconveniencefor field sampling and rapid testing,saliva is a rich body fluid with a number of physiologica ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  8. Automated Vision Tester Technology Development for Aircrew Clinical Vision Screening

    SBC: SA PHOTONICS, LLC            Topic: DHP16004

    Existing visual screening devices consist of illuminated test cards. By rotating the knob, images may be changed; however, once the system is loaded with cards it cannot be easily reconfigured. There are a limited number of cards that a unit can hold at one time, and it is impossible to change cards on the fly if a patients vision needs further investigation or if the clinician wants to do variabl ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  9. Diagnostic Device for Detecting Biomarkers of Early Multiorgan Injury in Saliva

    SBC: INNOSENSE CORPORATION            Topic: DHP16006

    DoD requires a single, multiplexed, saliva-based diagnostic bioassay to determine multiorgan injury-relevant systemic toxicity. This assay should quantitatively-detect clinically relevant biomarkers in saliva and validate organ injury arising from chemical/xenobiotic exposure. Innosense LLC (ISL) is building on its proprietary carbon nanotube platform to construct Nano-Mos for detecting salivary b ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  10. Novel Super-cooling of Genitourinary Cells and Tissues for Transplant

    SBC: X-Therma Inc.            Topic: DHP16012

    A key bottleneck to be addressed in regenerative medicine is hypothermic preservation of cells and tissues, which has been shown to extend survival of cell and tissue-based therapies by decreasing ischemic effect. However, preservation technology is aged, toxic and less effective than desired with typical cell survival post-thaw below 50% and unreliable potency. Current technology greatly hinders ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government